Market Cap

Aileron Therapeutics, Inc. Market Capitalization:

$45.7 Million

USD as of March 1, 2025

business Aileron Therapeutics, Inc. Company Profile

Aileron Therapeutics, Inc. Main Stock Listing

NASDAQ: ALRN

Market Capitalization History of Aileron Therapeutics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Aileron Therapeutics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $45.7 M 220.44%
Jan. 1, 2024 $14.3 M 4.77%
Jan. 1, 2023 $13.6 M 526.61%
Jan. 1, 2022 $2.2 M -74.54%
Jan. 1, 2021 $8.5 M 169.91%
Jan. 1, 2020 $3.2 M -38.36%
Jan. 1, 2019 $5.1 M -88.08%
Jan. 1, 2018 $43.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Aileron Therapeutics, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Aileron Therapeutics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: ALRN

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.